Elutia Inc (ELUT) Stock Price, Quote & News

Company Profile

Elutia Inc., a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation and breast reconstruction in the United States. It operates in three segments: Device Protection, Women's Health, and Cardiovascular. The company offers EluPro, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators; and CanGaroo, which mitigates complications derived from implantable electronic devices and shortcom...

Industry: Medical Devices

Sector: Healthcare

Phone: 240 247 1170

Fax: 408 734 2629

Website: elutia.com

Address:

12510 Prosperity Drive, Suite 370, Silver Spring, United States

Invest2live Feb. 14 at 12:01 AM

$ELUT 51% in a month already; congrats 🌿🎈🌿 Checkout $HUMA and $GERN

0 · Reply

OfficialStocktwitsUser Feb. 13 at 2:07 PM

$ELUT RSI: 50.11, MACD: 0.0497 Vol: 0.07, MA20: 0.96, MA50: 0.77 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

GammaGrid Feb. 9 at 2:20 PM

$ELUT E-liquid or vaping products; faces intense regulatory scrutiny.

0 · Reply

palo34 Feb. 6 at 10:20 PM

$ELUT dollar plus

0 · Reply

OfficialStocktwitsUser Jan. 30 at 2:03 PM

$ELUT RSI: 76.05, MACD: 0.0968 Vol: 0.15, MA20: 0.82, MA50: 0.70 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

AZOZ Jan. 30 at 1:00 PM

$ELUT Insider activity!

0 · Reply

storri23 Jan. 27 at 9:08 PM

$ELUT what a close. Excited for tomorrow open

0 · Reply

peepthestamp Jan. 26 at 6:40 PM

$ELUT

0 · Reply

peepthestamp Jan. 24 at 7:07 AM

$ELUT

0 · Reply

palo34 Jan. 22 at 7:33 PM

$ELUT hit one dollar milestone delisting could be off if sustained

0 · Reply

Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, and Upcoming NXT-41x Milestones

Jan 9, 2026, 8:00 AM EST - 5 weeks ago

Elutia to Present at Global BioInnovation Forum on NXT-41x Biomatrix Program for Plastic and Reconstructive Surgery

Nov 7, 2025, 12:16 AM EST - 3 months ago

Elutia Inc. (ELUT) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 4:05 PM EST - 3 months ago

Elutia Reports Third Quarter 2025 Financial Results; Closes $88 Million Sale of BioEnvelope Business to Boston Scientific Corporation; Funds NXT-41x Development

Oct 23, 2025, 4:05 PM EDT - 4 months ago

Elutia to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025

Oct 14, 2025, 4:05 PM EDT - 4 months ago

Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21

Oct 10, 2025, 8:00 AM EDT - 4 months ago

Elutia Appoints Accomplished MedTech Veteran Guido J. Neels to Board of Directors

Oct 1, 2025, 8:41 AM EDT - 4 months ago

Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million

Sep 16, 2025, 8:00 AM EDT - 5 months ago

Elutia Announces Newly Published Clinical Data Demonstrating that Biologic Envelopes Support CIED Stabilization and Ease of Reoperation

Sep 9, 2025, 8:30 AM EDT - 5 months ago

Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million

Sep 4, 2025, 8:00 AM EDT - 5 months ago

Elutia Selected to Exhibit EluPro™ Antibiotic Eluting BioEnvelope at Vizient Innovative Technology Exchange

Aug 27, 2025, 8:00 AM EDT - 6 months ago

Elutia to Participate in Upcoming Investor Conferences

Aug 14, 2025, 9:03 PM EDT - 6 months ago

Elutia Inc. (ELUT) Q2 2025 Earnings Call Transcript

Aug 14, 2025, 4:05 PM EDT - 6 months ago

Elutia Delivers Robust Growth on the Strength of EluPro™ Market Adoption

Jul 31, 2025, 4:05 PM EDT - 7 months ago

Elutia to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025

Jul 31, 2025, 8:00 AM EDT - 7 months ago

Dr. Michelle LeRoux Williams Earns Washington Business Journal's Medical Device Innovator Award

Jul 1, 2025, 8:00 AM EDT - 8 months ago

New Evidence Supports the Value of Elutia's Antibiotic-Eluting Platform for Implantable Devices

Jun 26, 2025, 8:00 AM EDT - 8 months ago

Elutia Wins Dual Honors for Innovation and Product Launches at 2025 Medical Device Network Excellence Awards

May 28, 2025, 8:00 AM EDT - 9 months ago

Elutia Strengthens Drug-Eluting Biomatrix Platform with Peer-Reviewed Publication of Novel EluPro™ Testing Method

May 11, 2025, 7:32 AM EDT - 9 months ago

Elutia Inc. (ELUT) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:05 PM EDT - 10 months ago

Elutia Announces Strong First Quarter 2025 Financial Results Driven by 84% Sequential Growth in EluPro™ Sales

May 1, 2025, 4:05 PM EDT - 10 months ago

Elutia Transitions to Direct Distribution of Its Cardiovascular Product Portfolio

May 1, 2025, 8:00 AM EDT - 10 months ago

Elutia to Report First Quarter 2025 Financial Results on Thursday, May 8, 2025

Apr 22, 2025, 4:05 PM EDT - 10 months ago

Elutia to Participate in Chardan's Trending Issues in Drug Development Conference Series on April 29

Apr 21, 2025, 8:00 AM EDT - 10 months ago

Elutia Initiates EluPro™ Registry Study Designed to Generate Evidence Supporting the Use of EluPro in Real-World Clinical Practice

Apr 14, 2025, 8:00 AM EDT - 10 months ago

Elutia Confirms No Material Impact from Global Tariffs

Apr 2, 2025, 4:05 PM EDT - 11 months ago

Elutia to Debut EluPro™ at HRS 2025 — Experience the Difference Biology Makes

Mar 27, 2025, 4:05 PM EDT - 11 months ago

Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro™

Mar 25, 2025, 4:05 PM EDT - 11 months ago

Elutia Advances Scientific Leadership with Publication of New Study on Antibiotic-Eluting Biologic Envelope

Mar 6, 2025, 6:22 PM EST - 1 year ago

Elutia Inc. (ELUT) Q4 2024 Earnings Call Transcript

Mar 6, 2025, 4:05 PM EST - 1 year ago

Elutia Announces Fourth Quarter and Full Year 2024 Financial Results: Strong Demand for EluPro™ in Pilot Launch Sets the Stage for Full Commercial Roll-Out

Feb 20, 2025, 4:05 PM EST - 1 year ago

Elutia to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, March 6, 2025

Feb 3, 2025, 6:30 AM EST - 1 year ago

Elutia Announces $15.0 Million Registered Direct Offering

Nov 14, 2024, 8:11 PM EST - 1 year ago

Elutia Inc. (ELUT) Q3 2024 Earnings Call Transcript

Oct 23, 2024, 4:05 PM EDT - 1 year ago

Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30

Sep 18, 2024, 8:00 AM EDT - 1 year ago

Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company's Antibiotic-Eluting BioEnvelope for Implantable Devices

Sep 6, 2024, 4:23 PM EDT - 1 year ago

Elutia Celebrates First Year

Sep 5, 2024, 4:05 PM EDT - 1 year ago

Elutia Announces First Patient Implant of EluPro™, the World's First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators

Aug 20, 2024, 7:00 AM EDT - 1 year ago

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

CIA CVKD EUDA GDTC GOSS GOVX IMRN

Aug 10, 2024, 7:27 AM EDT - 1 year ago

Elutia Inc. (ELUT) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 4:05 PM EDT - 1 year ago

Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations

Jul 11, 2024, 4:05 PM EDT - 1 year ago

Elutia to Present at the Emerging Growth Conference on Thursday, July 18

Jun 17, 2024, 8:01 AM EDT - 1 year ago

Elutia Announces $13.26 Million Registered Direct Offering

Jun 17, 2024, 8:00 AM EDT - 1 year ago

Elutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and Defibrillators

May 12, 2024, 12:21 PM EDT - 1 year ago

Elutia, Inc. (ELUT) Q1 2024 Earnings Call Transcript

Apr 24, 2024, 4:05 PM EDT - 1 year ago

Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1

Mar 7, 2024, 8:43 PM EST - 2 years ago

Elutia, Inc. (ELUT) Q4 2023 Earnings Call Transcript

Mar 7, 2024, 4:05 PM EST - 2 years ago

Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM® Clearance Decision in First Half of 2024

Feb 22, 2024, 4:05 PM EST - 2 years ago

Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024

Jan 10, 2024, 4:05 PM EST - 2 years ago

Elutia Regains Compliance with Nasdaq Listing Requirements

Invest2live Feb. 14 at 12:01 AM

$ELUT 51% in a month already; congrats 🌿🎈🌿 Checkout $HUMA and $GERN

0 · Reply

OfficialStocktwitsUser Feb. 13 at 2:07 PM

0 · Reply

GammaGrid Feb. 9 at 2:20 PM

$ELUT E-liquid or vaping products; faces intense regulatory scrutiny.

0 · Reply

palo34 Feb. 6 at 10:20 PM

$ELUT dollar plus

0 · Reply

OfficialStocktwitsUser Jan. 30 at 2:03 PM

0 · Reply

AZOZ Jan. 30 at 1:00 PM

$ELUT Insider activity!

0 · Reply

storri23 Jan. 27 at 9:08 PM

$ELUT what a close. Excited for tomorrow open

0 · Reply

peepthestamp Jan. 26 at 6:40 PM

$ELUT

0 · Reply

peepthestamp Jan. 24 at 7:07 AM

$ELUT

0 · Reply

palo34 Jan. 22 at 7:33 PM

$ELUT hit one dollar milestone delisting could be off if sustained

0 · Reply

Lyn30 Jan. 22 at 5:23 PM

$ELUT Now u chase with rocket I m relaxed sitting

0 · Reply

Lyn30 Jan. 22 at 3:38 PM

$ELUT So far good ✅

0 · Reply

lucidi Jan. 21 at 8:26 PM

$ELUT we will see $5 soon.

0 · Reply

Tradingpirate Jan. 21 at 5:23 PM

$ELUT Getting ready to be the next runner...

0 · Reply

Invest2live Jan. 14 at 3:48 AM

$ELUT 19% today; congrats 🎊 if you got the cheap shares 🎉🎈

0 · Reply

Invest2live Jan. 13 at 9:05 PM

$NGD 1428% already; congrats 🎊 🎉🎈 Check out $ELUT and $AKBA; these have potential to double

0 · Reply

DARKP00L Jan. 13 at 8:50 PM

$ELUT massive Volume Spike! In this stock is generating a lot of buzz today!

0 · Reply

Invest2live Jan. 13 at 8:50 PM

$ASRT 5% already in a few hours; congrats 🎉 🎊🌿🎈 This has long way to go; check out $ELUT and $AKBA; both are undervalued and have great potential

0 · Reply

Invest2live Jan. 13 at 8:47 PM

$IPSC 303% already; congrats 🎉 🎈🎊 Checkout $ELUT and $AKBA; both have similar potential for longs. Do your DD and get in.

0 · Reply

DARKP00L Jan. 13 at 8:25 PM

$ELUT momentum building! Stock attracting attention, could be a mover!

0 · Reply

lucidi Jan. 13 at 8:10 PM

$ELUT beautiful

0 · Reply

Invest2live Jan. 13 at 7:54 PM

$ELUT 14% already today; 1+ is coming.

0 · Reply

Market Cap	40.62M
Revenue (ttm)	24.38M
Net Income (ttm)	-53.95M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-221.29%
Debt to Equity Ratio	-0.59

Volume	192,200
Avg Vol	414,750
Day's Range	N/A - N/A
Shares Out	42.70M
Stochastic %K	74%
Beta	0.67
Analysts	Strong Sell
Price Target	$3.50